Keeler Thomas Management
RMD icon

Keeler Thomas Management’s ResMed RMD Stock Holding History

Keeler Thomas Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.64M Sell
11,942
-58
-0.5% -$12.7K 1.03% 23
2026
Q2 		$2.34M Buy
12,000
+1,919
+19% +$398K 0.83% 35
2026
Q1 		$2.26M Buy
10,081
+4,725
+88% +$1.18M 0.96% 39
2025
Q4 		$1.29M Buy
5,356
+7
+0.1% +$1.79K 0.61% 54
2025
Q3 		$1.46M Buy
5,349
+70
+1% +$19.1K 0.6% 52
2025
Q2 		$1.36M Buy
+5,279
New +$1.26M 0.59% 52

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Keeler Thomas Management's RMD Position: Q3 2026 in Review

Keeler Thomas Management reduced its ResMed (RMD) stake by 0.48% in Q3 2026, selling an estimated $12.7K and leaving 11,942 shares worth $2.64M. The position accounts for 1.03% of the portfolio, ranked #23.

Keeler Thomas Management first reported a position in RMD in Q2 2025 and has held it in 6 quarters since. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Keeler Thomas Management held 11,942 shares of ResMed worth $2.64M as of Q3 2026.
  • Keeler Thomas Management sold 58 ResMed shares in Q3 2026, an estimated $12.7K.
  • ResMed made up 1.03% of Keeler Thomas Management's portfolio in Q3 2026, its #23 holding.
  • Keeler Thomas Management first reported a position in ResMed in Q2 2025 and has held it in 6 quarters since.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Keeler Thomas Management's 13F filing for Q3 2026, filed 29 Oct 2026.